P05.03 OptimalTTF-1: Final results of a phase 1 study at first glioblastoma recurrence examining targeted craniotomy to enhance Tumor Treating Fields intensity

BACKGROUND: OptimalTTF-1 is an open-label phase-1 study on the combination of Tumor Treating Fields (TTFields) treatment together with targeted skull remodeling surgery aiming to enhance the electric field intensity in the brain (NCT02893137). Skull-remodeling surgery (SR-surgery) in this trial aims...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Korshøj, A R, Mikic, N, Lukacova, S, Sørensen, J C H, Hansen, F L, Thielscher, A, Cortnum, S O S, Guldberg, T L, Ramshad-Lassen, Y, Rahbek, C, Severinsen, K E, von Oettingen, G
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796057/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.117
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars